# Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above

> **NCT07152639** · PHASE3 · RECRUITING · sponsor: **Chengdu CoenBiotech Co., Ltd** · enrollment: 1784 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **BIOLOGICAL:** 5μg/ml EEC
- **BIOLOGICAL:** 5 unit（U） EC
- **BIOLOGICAL:** 5 IU TB-PPD
- **DIAGNOSTIC_TEST:** IGRA

## Key facts

- **NCT ID:** NCT07152639
- **Lead sponsor:** Chengdu CoenBiotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-09
- **Primary completion:** 2026-05-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 1784 (ESTIMATED)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07152639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07152639, "Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT07152639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*